Gene Therapy Market To Witness A Significant Growth Rate In The Forecast Years from 2018-2026: Grand View Research Inc.
San
Francisco, 25 February 2019: The Report GeneTherapy Market Size, Share & Trends Analysis Report By Indication (Cancer, Genetic
Disorders, Infectious Diseases, CVD, Neuro Disorders), By Vector Type (Viral,
Non-Viral), By Region, and Segment Forecasts, 2018 – 2026
The global gene
therapy market size is expected to reach USD 39.54 million by 2026. Rising
competition among manufacturers and high number of molecules in pipeline are
supporting the growth of the market.
Gene therapy
development is aimed to cure rare diseases and even some hereditary diseases,
which are caused by a mutated or faulty gene. Moreover, ever-increasing need
for new cures for orphan diseases and rising incidence of cancer caused due to
mutations in genes are likely to stir up the demand for gene therapy.
As of early
2016, there were more than 1000 molecules in the pipeline in various clinical
phases. However, around 76.0% of the molecules are in the developmental or
preclinical stages and expected to hit the market in late 2020’s.
A great
number of large pharma/biotech players are estimated to acquire small firms as
many have been trying to develop in-house expertise and build their own
pipelines. This trend is anticipated to help the market gain tremendous
traction over the coming years. Combination of gene therapy with small
molecules or protein therapy is said to have lesser side effects and better
efficacy as compared to gene therapy alone.
Cancer held
the dominant share in the market in 2017 owing to relatively high adoption of
gene therapies for cancer treatment. Continual rise in new cancer cases and
related mortality per year triggers the need for development of robust
treatment options. Ongoing developments in cancer gene studies have provided
significant information about cancer-related molecular signatures, which in
turn, is projected to support ongoing clinical trials for cancer therapeutics.
Access Research Report of
Gene Therapy Market @ www.grandviewresearch.com/industry-analysis/gene-therapy-market
Further Key Findings from the Study
Suggest:
·
More than 60.0% of the market is
occupied by cancer research owing to a large pipeline.
·
Adenoviral vectors are the most used
in pipeline development, closely followed by retroviral vectors.
·
Europe and the U.S. are poised to
occupy the largest cumulative share in the market throughout the forecast
period.
·
Asia Pacific is set to post
noteworthy CAGR during the forecast period, owing to growing pipeline molecules
and a large number of companies competing in the market.
·
Some of the key players in this
market are UniQure N.V, Spark Therapeutics LLC, Bluebird Bio, Juno
Therapeutics, GlaxoSmithKline, Celgene Corporation, Shire Plc, Sangamo
Biosciences, Dimension Therapeutics, Voyager Therapeutics, Human Stem Cell
Institute, Bristol Myer’s Squibb, and Chiesi Farmaceutici S.p.A.
Grand View Research Has Segmented the Global Gene Therapy
Market by Indication, Vector Type, and Region:
Gene Therapy Indication Outlook
(Revenue, USD Million, 2014 - 2026)
·
Cancer
·
Cardio Vascular Diseases
·
Infectious Diseases
·
Genetic Disorders
·
Neuro Disorders
·
Others
Gene Therapy Vector Type
Outlook (Revenue, USD Million, 2014 - 2026)
·
Viral Vectors
o
Retrovirus
o
Adenovirus
o
Adeno-Associated Virus
o
Vaccinia Virus
o
Herpes Simplex Virus
o
Others
·
Non-Viral Vectors
o
Injection Of Naked DNA
o
Lipofection
o
Others
Gene Therapy Regional Outlook (Revenue,
USD Million, 2014 - 2026)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
U.K.
·
Asia Pacific
o
China
o
Japan
·
Latin America
o
Brazil
·
MEA
o
South Africa
Access
Press Release of Gene Therapy Market @ www.grandviewresearch.com/press-release/global-gene-therapy-market
Grand
View Research, Inc. is a U.S. based market research and consulting company, registered
in the State of California and headquartered in San Francisco. The company
provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment